Hosted on MSN3d
France to reimburse new implants for breast cancer patientsFrench lawmakers have voted unanimously to ensure breast cancer patients no longer have to pay out of pocket for the ...
Woman&Home on MSN22h
"Cancer was just a job, until it happened to me" – a doctor shares her moving breast cancer storyAuthor, speaker and health content creator Dr Liz O’Riordan shares her journey from consultant breast surgeon to cancer ...
As seen in the DESTINY-Breast06 trial, approximately 20-25 percent of hormone receptor (HR)-positive, HER2-negative breast cancer patients may be considered HER2-ultralow.1 These patients may now be ...
According to the National Cancer Institute, approximately 40.5% of Americans will be diagnosed with cancer at some point ...
Allison Ciaccio had a respiratory illness that wouldn't go away. Repeated follow-ups found Stage I lung cancer.
GlobalData on MSN3d
FDA expands Enhertu approval to include HER2-ultralow breast cancer patientsAstraZeneca and Daiichi Sankyo’s antibody-drug conjugate (ADC) Enhertu (trastuzumab deruxtecan) has received approval from ...
Patients diagnosed with more advanced breast cancer are more likely to have cardiovascular disease, a large study suggests.
The University of Iowa study is analyzing the period between breast cancer diagnosis and treatment, when many patients feel ...
3don MSN
A new study led by researchers at Moffitt Cancer Center shows that asymptomatic brain metastasis is more common in stage 4 ...
The process impacts physical movement and emotional well-being, but specific stretching exercises can significantly improve ...
The antibody drug conjugate was approved for patients with unresectable or metastatic HER2-low or -ultralow breast cancer ...
A Peter Mac-led international clinical trial has shown adding an immunotherapy drug to the chemotherapy that patients receive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback